The time of day for cancer immunotherapy is associated with major outcomes. Early is better. Results from a randomized trial of lung cancer, backs up the importance of our circadian rhythm and immune system
https://t.co/bHqUZ3U83O
A great deep dive by @kelsyketchum about our growing portfolio of precision medicine solutions and how we plan to continue to build and scale our AI-enabled platform to support physicians and researchers.
I have been struggling to articulate the complex emotions I've been feeling since Saturday morning as a Jew, a liberal/progressive, a believer that Palestinians and Jews have a right to a homeland, to safety and dignity. A thread 1/
#NEWS: Together with @GSK, we are leveraging data and AI to improve oncology drug targets and #clinicaltrial design to provide patients with more personalized treatment faster. Read more here: https://t.co/Fr919fQvPd
The past weeks events in Chicago are instructive of America's gun problems.
We're all aware of the horror in Highland Park.
But just as many people were killed in Chicago last weekend as part of the every day shooting events plaguing urban America (1/5)
https://t.co/Av36R7puTQ
@Klonick@Hertz This also happened to me, except I wasn’t told the price change bc I prepaid for the car and was charged after. I refused to pay and am blocked from renting a car until I do, despite being Presidents Circle with Hertz for years. Still haven’t gotten this removed after many calls!
Western worries about Covid vaccines from Johnson & Johnson and AstraZeneca could tarnish their image in countries where people sorely need them. https://t.co/3RAIrnyB6f
A janitor making $4/hour walked into a Fortune 500 company boardroom. Shaking, he took a seat opposite the CEO.
"So I had an idea..." he nervously began.
Years later, that idea would become an iconic consumer brand and make him worth ~$20M.
Here's how that meeting went 🧶👇
UPDATE: The @MHRAgovuk issued a temporary authorization for emergency use of our #COVID19 vaccine with @BioNTech_Group in the United Kingdom.
This marks the first authorization of a vaccine to help fight the pandemic following a worldwide trial.
This will go down in history as one of science and medical research's greatest achievements. Perhaps the most impressive.
I put together a preliminary timeline of some key milestones to show how several years of work were compressed into months.
BREAKING: We are proud to announce, along with @BioNTech_Group, that the Phase 3 study of our #COVID19 vaccine candidate has met all primary efficacy endpoints.
1. Turning this into a brief thread. The prelim analysis — 90% efficacy — from the Pfizer #covid19 vaccine is very encouraging news re this vaccine AND....
While I may be the first woman in this office, I will not be the last—because every little girl watching tonight sees that this is a country of possibilities.